Author:
Pozuelo Torres Marta,van Ingen Jakko
Reference31 articles.
1. Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis;Kwak;Eur Respir J,2019
2. Mycobacterium abscessus L,D-transpeptidases are susceptible to inactivation by carbapenems and cephalosporins but not Penicillins;Kumar;Antimicrob Agents Chemother,2017
3. Insights into the L,D-transpeptidases and D,D-carboxypeptidase of Mycobacterium abscessus: ceftaroline, imipenem, and novel diazabicyclooctane inhibitors;Dousa;Antimicrob Agents Chemother,2020
4. “One-two punch”: synergistic ß-lactam combinations for Mycobacterium abscessus and target redundancy in the inhibition of peptidoglycan synthesis enzymes;Nguyen;Clin Infect Dis,2021
5. First penicillin-binding protein occupancy patterns for 15 β-lactams and β-lactamase inhibitors in Mycobacterium abscessus;Sayed;Antimicrob Agents Chemother,2020